Brain tumor rehabilitation

American Journal of Physical Medicine and Rehabilitation

Volumn 90, Issue SUPPL.5, 2011, Pages

  Vargo, Mary ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Brain tumors; Cancer rehabilitation; Central nervous system tumors; Cognitive therapy; Collaboration; Treatment

Indexed keywords

ADULT; BRAIN TUMOR; CHILD; HUMAN; PSYCHOLOGICAL ASPECT; REVIEW;

ADULT; BRAIN NEOPLASMS; CHILD; HUMANS;

EID: 79955008781     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e31820be31f     Document Type: Article

References (91)

1. Lehmann J, DeLisa JA, Warren CG, et al: Cancer rehabilitation assessment of need development and education of a model of care. Arch Phys Med Rehabil 1978;59:410-9 (Pubitemid 9025186)
2. American Cancer Society. Cancer facts and figures 2009. Atlanta, GA: American Cancer Society, 2009. Available at: http://www.cancer.org. Accessed on January 19, 2010
3. Horner MJ, Ries LAG, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975Y2006. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2006/
4. Barnholtz-Sloan JS, Sloan AE, Schwartz AG: Chapter 25. Cancer of the brain and other central nervous system. SEER Survival Monograph. Available at:Seer.cancer.gov/publications/survival/surv-brain.pdf
5. Gurney JG, Smith MA, Bunin GR: CNS and miscellaneous intracranial and intraspinal neoplasms. SEER Pediatric Monograph. Bethesda, National Cancer Institute, http://seer.cancer.gov/publications/childhood/cns.pdf
6. Central Brain Tumor Registry of the United States data, 2000-2004. Available at: http://www.cbtrus.org/factsheet/factsheet.html
7. Buckner JC, Brown PD, O'Neill BP: Central nervous system tumors. Mayo Clin Proc 2007;82:1271-86 (Pubitemid 47502884)
8. American Brain Tumor Association Web site. Available at: http://www.abta.org/
9. Coronado VGMD, Johnson RL, Faul M: Incidence rates of hospitalization related to traumatic brain injuryV12 States, 2002. JAMA 2006;295:1764-5.
10. Also MMWR Morb Mortal Wkly Rep. 2006;55:201-4
11. Thurman DJ, Alverson C, Dunn KA, et al: Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil 1999;14:602-15 (Pubitemid 30027268)
12. Russo CA, Andrews RM: Hospital Stays for Stroke and Other Cerebrovascular Diseases, 2005. May 2008. HCUP Statistical Brief 51. http://www.hcup-us.ahrq. gov/reports/statbriefs/sb51.pdf
13. DeAngelis LM, Loeffler JS, Mamelak AN: Primary and metastatic brain tumors. Chapter 26, in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (eds): Cancer Management: A Multidisciplinary Approach, ed 11. 2008. Available at: http://www.cancernetwork.com/cancer-management-11/chapter26/article/10165/ 1406429
14. Stupp R, Mason WP, van den Bent MJ: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Eng J Med 2005;352:987-96 (Pubitemid 40349501)
15. Muller HL: Childhood craniopharyngioma. Recent advances in diagnosis, treatment, and follow-up. Horm Res 2008;69:193-202 (Pubitemid 351562907)
16. Waber DP, Pomeroy SL, Chiverton AM, et al: Everyday cognitive function after craniopharyngioma in childhood. Pediatr Neurol 2006;34:13-9 (Pubitemid 41821003)
17. Ribi K, Relly C, Landolt MA: Outcome of medulloblastoma in children: long term complications and quality of life. Neuropediatrics 2005;36:357-65 (Pubitemid 43162346)
18. Grimm SA, DeAngelis LM: Neurological complications of chemotherapy and radiation therapy, in Aminoff MJ (ed). Neurology and General Medicine, ed 4. New York, NY: Churchill Livingstone, 2007: 523. Available at: http://www. aboutcancer.com/brain-radiation-comps-aminoff.htm
19. Zubair S: Central nervous system complications of radiation. Available at: www.medlink.com/web-content/index/MLT00031.asp
20. Butler RW, Sahler OJZ, Askins MA, et al: Interventions to improve neuropsychological functioning in childhood cancer survivors. Dev Disabil Res Rev 2008;14:251-8
21. Wen PY, Norden AD, Drappatz J: Antiangiogenic therapies for malignant glioma. ASCO Educational Book 2009;113-17
22. Mukand JA, Blackinton DD, Crincolli MG, et al: Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil 2001;80:346-50 (Pubitemid 32378119)
23. Hahn CA, Dunn RH, Logue PE, et al: Prospective study of neuropsychologic testing and QOL assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 2003;55:992-9 (Pubitemid 36287002)
24. O'Dell, et al: Functional outcome of inpatient rehabilitation in persons with brain tumors. Arch Phys Med Rehabil 1998;79:1530-4
25. Huang, et al: Functional outcome after brain tumor and acute stroke: a comparative analysis. Arch Phys Med Rehabil 1998;79:1386-90 (Pubitemid 28525122)
26. Greenberg E, Treger I, Ring H: Rehabilitation outcomes in patients with brain tumors and acute stroke: comparative study of inpatient rehabilitation. Am J Phys Med Rehabil 2006;85:568-73 (Pubitemid 43941563)
27. Geler-Kulcu D, Gulsen G, Buyukbaba E, et al: Functional recovery of patients with brain tumor or acute stroke after rehabilitation: a comparative study. J Clin Neurosci 2009;16:74Y8
28. Marciniak CM, Sliwa JA, Spill G, et al: Functional outcome following rehabilitation of the cancer patient. Arch Phys Med Rehabil 1996;77:54-7 (Pubitemid 26017492)
29. Marciniak CM, Sliwa JA, Heinemann AW, et al: Functional outcomes of persons with brain tumors after inpatient rehabilitation. Arch Phys Med Rehabil 2001;82:457Y63 (Pubitemid 32289707)
30. Kirshblum S, O'Dell MW, Ho C, et al: Rehabilitation of persons with central nervous system tumors. Cancer 2001;92:1029-38
31. Alam E, Wilson RD, Vargo M: Inpatient cancer rehabilitation: a retrospective comparison of transfer back to acute care between patients with neoplasm and other rehabilitation patients. Arch Phys Med Rehabil 2008;89(suppl):1284-9 (Pubitemid 351884997)
32. Kidd D, Stewart G, Baldry J, et al: The Functional Independence Measure: a comparative validity and reliability study. Disabil Rehabil 1995;17:10-4
33. Brazil L, Thomas R, Laing R, et al: Verbally administered Barthel Index as functional assessment in brain tumor patients. J Neurooncol 1997;34:187-92 (Pubitemid 27271725)
34. Weitzner M, Meyers CA, Gelke CK, et al: Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 1995;75:1151-61
35. Holtzman J, Schmitz K, Babes G, et al: Effectiveness of Behavioral Interventions to Modify Physical Activity Behaviors in General Populations and Cancer Patients and Survivors. Summary, Evidence Report/Technology Assessment No. 102. Rockville, MD: Agency for Healthcare Research and Quality, 2004. AHRQ Publication No. 04-E027-1
36. Hempen C, Weiss E, Hess CF: Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the sideeffects? Support Care Cancer 2002;10:322-8 (Pubitemid 36056287)
37. Nahaczewski AE, Fowler SB, Hariharan S: Dexamethasone therapy in patients with brain tumorsVa focus on tapering. J Neurosci Nurs 2004;36:340-3
38. Horber FF, Hoopeler H, Scheidegger JR, et al: Impact of physical training on the ultrastructure of midthigh muscle in normal subjects and in patients treated with glucocorticoids. J Clin Invest 1987;79: 1181-90 (Pubitemid 17065500)
39. Horber FF, Scheidegger JR, Grunig BE, et al: Thigh muscle mass and function in patients treated with glucocorticoids. Eur J Clin Invest 1985;15:302-7 (Pubitemid 16185734)
40. Czerwinski SM, Kurowski TG, O'Neill TM, et al: Initiating regular exercise protects against muscleatrophy from glucocorticoids. J Appl Physiol 1987; 63:1504-10 (Pubitemid 18024190)
41. Jones LW, Guill B, Keir ST: Exercise interest and preferences among patients diagnosed with primary brain cancer. Support Care Cancer 2007;15:47-55 (Pubitemid 46088313)
42. Schubart JR, Kinzie MB, Farace E: Caring for the brain tumor patient: family caregiver burden and unmet needs. Neuro-Oncology 2008;10:61-72 (Pubitemid 351250901)
43. Lovely M: Symptom management of brain tumor patients. Semin Oncol Nurs 2004;20:273-83 (Pubitemid 39488324)
44. Short PF, Vasey JJ, Tunceli K: Employment pathways in a large cohort of adult cancer survivors. Cancer 2005;103:1292-301 (Pubitemid 40328102)
45. Taskila-Abrandt T, Martikainen R, Virtanen SV, et al: The impact of education and occupation on the employment status of cancer survivors. Eur J Cancer 2004;40:2488-93 (Pubitemid 39424965)
46. Ness KK, Mertens AC, Hudson MM, et al: Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Ann Intern Med 2005;143:639-47
47. Armstrong TS, Cohen MZ, Eriksen LR, et al: Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J Nurs Scholarsh 2004;36:197-206 (Pubitemid 41725172)
48. Fox SW, Lyon D, Farace E: Symptom clusters in patients with high-grade glioma. J Nurs Scholarsh 2007;39:61-7
49. Franklin DJ, Packel L: Cancer-related fatigue. Arch Phys Med Rehabil 2006;87:91-3
50. Taphoorn MJB, Schiphorst AK, Snoek FJ, et al: Cognitive function and quality of life in patients with low grade gliomas: the impact of radiotherapy. Ann Neurol 1994;36:48-54 (Pubitemid 24205823)
51. Ziai W: Chapter 36. Headache and other neurologic complications. In Berger AM, Shuster JH, Von Roenn JH, eds. Palliative Care and Supportive Oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:401-14
52. Meyers CA, Weitzner MA Valentine AD, et al: Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998;16:2522-7 (Pubitemid 28309050)
53. Thompson SJ, Leigh L, Christensen R: Immediate neurocognitive effects ofmethylphenidate on learningimpaired survivors of childhood cancer. J Clin Oncol 2001;19:1802-8 (Pubitemid 32230883)
54. Mulhern RK, Khan RB, Kaplan S: Short term efficacy of methylphenidate: a randomized, double-blind, placebo controlled trial among survivors of childhood cancer. J Clin Oncol 2004;22:4795-803
55. Gehring K, Sitskoorn MM, Aaronson NK, et al: Interventions for cognitive deficits in adults with brain tumours. Lancet Neurol 2008;7:548-60 (Pubitemid 351657495)
56. Gehring K, Sitskoorn MM, Gundy CM: Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol 2009;27: 3712-22
57. Locke DEC, Cerhan JH, Wu W: Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumors: a pilot study. J Cogn Support Oncol 2008;6:383-91
58. Lageman SK, Cerhan JH, Locke DE, et al: Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials [published online ahead of print 2009]. J Neurooncol 2010;96: 271-6.
59. Mulhern RK, Merchant TE, Gajjar A, et al: Late neurocognitive sequelae in survivors of brain tumors in childhood. Lancet Oncol 2004;5:399-408 (Pubitemid 38878043)
60. Konczak J, Schoch B, Dimitrova A: Functional recovery of children and adolescents after cerebellar tumor resection. Brain 2005;128:1428-41 (Pubitemid 40826195)
61. Poggi G, Liscio M, Adduci A, et al: Psychological and adjustment problems due to acquired brain lesion in childhood: a comparison between post-traumatic patients and brain tumor survivors. Brain Inj 2005; 19:777-85 (Pubitemid 40990639)
62. Dropcho EJ, Soong S-J: Steroid-induced weakness in patients with primary brain tumors. Neurology 1991;41:1235-9
63. Horber FF, Scheidegger JR, Grunig BE, et al: Evidence that prednisone-induced myopathy is reversed by physical training. J Clin Endocrinol Metab 1985; 61:83-8 (Pubitemid 15046199)
64. Vecht CJ, van Breemen M: Optimizing therapy of seizures in patients with brain tumors. Neurology 2006;67(suppl):S10-3 (Pubitemid 44967990)
65. Thompson D, Takeshita J, Thompson T, et al: Selecting antiepileptic drugs for symptomatic patients with brain tumors. J Support Oncol 2006;4:411-6 (Pubitemid 44541018)
66. Meador K, Gevins A, Loring DW: Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. Neurology 2007;69:2076-84 (Pubitemid 350175710)
67. Michelucci R: Optimizing therapy of seizures in neurosurgery. Neurology 2006;67(suppl):S14-8 (Pubitemid 44967991)
68. Karceski S, Morrell MJ, Carpenter D: Treatment of epilepsy in adults: expert opinion 2005. Epilepsy Behav 2005;7:S1-64 (Pubitemid 41131320)
69. Glantz MJ, Cole BF, Friedberg MH, et al: A randomized, blinded, placebo controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 1996;46:985-91 (Pubitemid 26134639)
70. Forsyth PA, Weaver S, Fulton D, et al: Prophylactic anticonvulsants in patients with brain tumor. Can J Neurol Sci 2003;30:106-12 (Pubitemid 36717992)
71. Sirven JI, Wingerchuk DM, Drazkowski JF, et al: Seizure prophylaxis in patients with brain tumors: a metaanalysis. Mayo Clin Proc 2004;79:1489-94 (Pubitemid 39578871)
72. Drappatz J, Schiff D, Kesari S, et al: Medical management of brain tumor patients. Neurol Clin 2007;25:1035-71 (Pubitemid 47610811)
73. Cascino GD: Epilepsy and brain tumors: implications for treatment. Epilepsia 1990;31(suppl):S37-44
74. Herman ST: Epilepsy after brain insult: targeting epileptogenesis. Neurology 2002;59(suppl):S21-6 (Pubitemid 35285971)
75. Moots PL, Maciunas RJ, Eisert DR, et al: The course of seizure disorders in patients with malignant gliomas. Arch Neurol 1995;52:717-24
76. Glantz MJ, Cole BF, Forsyth PA, et al: Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standard Subcommittee of the American Academy of Neurology. Neurology 2000;54:1886-93
77. Foy PM, Chadwick DW, Rajgopalan N, et al: Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? J Neurol Neurosurg Psychiatry 1992;55:753-7
78. North JB, Penhall RK, Hanieh A, et al: Phenytoin and postoperative epilepsy. A double blind study. J Neurosurg 1983;58:672-7 (Pubitemid 13131507)
79. Gerber DE, Grossman SA, Streiff MB: Management ofvenous thromboembolism in patients with primary and metastatic brain tumors. J Clin Oncol 2006;24:1310-8 (Pubitemid 46622035)
80. Knovich MA, Lesser GJ: The management of thromboembolic disease in patients with central nervous system malignancies. Curr Treat Options Oncol 2004; 5:511-7 (Pubitemid 39591810)
81. Sawaya R, Zuccarello M, Elkalliny M: Postoperative venous thromboembolism and brain tumors: part I. J Neurooncol 1992;14:119-25
82. Streiff MB, Segal J, Grossman SA, et al: ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas. Cancer 2004;100:1717-23 (Pubitemid 38456351)
83. Levin JM, Schiff D, Loeffler JS: Complications of therapy for venous thromboembolic disease in patients with brain tumors. Neurology 1993;43:1111-4 (Pubitemid 23177708)
84. Goldhaber SZ, Dunn K, Gerhard-Herman M, et al: Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 2002;122:1933-7 (Pubitemid 36051127)
85. Quevedo JF, Buckner JC, Schmidt JL, et al: Thromboembolism in patients with high-grade glioma. Mayo Clin Proc 1994;69:329-32 (Pubitemid 24108182)
86. Collen JF, Jackson JL, Shorr AF, et al: Prevention of venous thromboembolism in neurosurgery. Chest 2008;134:237-49
87. Perry JR, Rogers L, Laperriere N, et al: PRODIGE: a phase III randomized placebo-controlled trial of thromboprophylaxis using dalteparin low molecular weight heparin (LMWH) in patients with newly diagnosed malignant glioma. J Clin Oncol 2007;25:2011
88. Goldberg G: Mild traumatic brain injury and concussion. Phys Med Rehab 2001;15:363-98
89. Lew HL, Pin P-H, Fuh J-L: Characteristics and treatment of headache after traumatic brain injury. Am J Phys Med Rehabil 2006;85:619-27 (Pubitemid 43941570)
90. Wesling M, Brady S, Jensen M: Dysphagia outcomes in patients with brain tumors undergoing inpatient rehabilitation. Dysphagia 2003;18:203-10 (Pubitemid 36959291)
91. Pace A, Lorenzo CD, Guariglia L, et al: End of life issues in brain tumor patients. J Neurooncology 2009;91:39-43